The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Solid Dosage Contract Manufacturing-Global Market Insights and Sales Trends 2024
Synopsis
The global Oral Solid Dosage Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oral Solid Dosage Contract Manufacturing in various end use industries. The expanding demands from the Specialty/Midsize, Generics, Big Pharma and Other, are propelling Oral Solid Dosage Contract Manufacturing market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Oral Solid Dosage Contract Manufacturing market, driven by demand from China, the second largest economy with some signs of stabilising, the Oral Solid Dosage Contract Manufacturing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Solid Dosage Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Solid Dosage Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Solid Dosage Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Solid Dosage Contract Manufacturing covered in this report include Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc.
The global Oral Solid Dosage Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Catalent
DPx
Lonza Group (Capsugel)
Piramal Pharma Solutions
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie Contract Manufacturing
Nipro Pharma
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma
Dishman
Aesica Pharmaceuticals
CordenPharma
Global Oral Solid Dosage Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Solid Dosage Contract Manufacturing market, Segment by Type:
Tablets
Capsules
Powders & Granules
Others
Global Oral Solid Dosage Contract Manufacturing market, by Application
Specialty/Midsize
Generics
Big Pharma
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Oral Solid Dosage Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oral Solid Dosage Contract Manufacturing in various end use industries. The expanding demands from the Specialty/Midsize, Generics, Big Pharma and Other, are propelling Oral Solid Dosage Contract Manufacturing market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Oral Solid Dosage Contract Manufacturing market, driven by demand from China, the second largest economy with some signs of stabilising, the Oral Solid Dosage Contract Manufacturing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Solid Dosage Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Solid Dosage Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Solid Dosage Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Solid Dosage Contract Manufacturing covered in this report include Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc.
The global Oral Solid Dosage Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Catalent
DPx
Lonza Group (Capsugel)
Piramal Pharma Solutions
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie Contract Manufacturing
Nipro Pharma
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma
Dishman
Aesica Pharmaceuticals
CordenPharma
Global Oral Solid Dosage Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Solid Dosage Contract Manufacturing market, Segment by Type:
Tablets
Capsules
Powders & Granules
Others
Global Oral Solid Dosage Contract Manufacturing market, by Application
Specialty/Midsize
Generics
Big Pharma
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oral Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Oral Solid Dosage Contract Manufacturing
1.1 Oral Solid Dosage Contract Manufacturing Market Overview
1.1.1 Oral Solid Dosage Contract Manufacturing Product Scope
1.1.2 Oral Solid Dosage Contract Manufacturing Market Status and Outlook
1.2 Global Oral Solid Dosage Contract Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oral Solid Dosage Contract Manufacturing Market Size by Region (2018-2029)
1.4 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Oral Solid Dosage Contract Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oral Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.1 North America Oral Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.2 Europe Oral Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.4 Latin America Oral Solid Dosage Contract Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size (2018-2029)
2 Oral Solid Dosage Contract Manufacturing Market by Type
2.1 Introduction
2.1.1 Tablets
2.1.2 Capsules
2.1.3 Powders & Granules
2.1.4 Others
2.2 Global Oral Solid Dosage Contract Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Type (2018-2029)
3 Oral Solid Dosage Contract Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Specialty/Midsize
3.1.2 Generics
3.1.3 Big Pharma
3.1.4 Other
3.2 Global Oral Solid Dosage Contract Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oral Solid Dosage Contract Manufacturing Revenue Breakdown by Application (2018-2029)
4 Oral Solid Dosage Contract Manufacturing Competition Analysis by Players
4.1 Global Oral Solid Dosage Contract Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Solid Dosage Contract Manufacturing as of 2022)
4.3 Date of Key Players Enter into Oral Solid Dosage Contract Manufacturing Market
4.4 Global Top Players Oral Solid Dosage Contract Manufacturing Headquarters and Area Served
4.5 Key Players Oral Solid Dosage Contract Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Oral Solid Dosage Contract Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Catalent
5.1.1 Catalent Profile
5.1.2 Catalent Main Business
5.1.3 Catalent Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.1.4 Catalent Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Catalent Recent Developments
5.2 DPx
5.2.1 DPx Profile
5.2.2 DPx Main Business
5.2.3 DPx Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.2.4 DPx Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 DPx Recent Developments
5.3 Lonza Group (Capsugel)
5.3.1 Lonza Group (Capsugel) Profile
5.3.2 Lonza Group (Capsugel) Main Business
5.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.3.4 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Piramal Pharma Solutions Recent Developments
5.4 Piramal Pharma Solutions
5.4.1 Piramal Pharma Solutions Profile
5.4.2 Piramal Pharma Solutions Main Business
5.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.4.4 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Piramal Pharma Solutions Recent Developments
5.5 Aenova
5.5.1 Aenova Profile
5.5.2 Aenova Main Business
5.5.3 Aenova Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.5.4 Aenova Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Aenova Recent Developments
5.6 Jubilant
5.6.1 Jubilant Profile
5.6.2 Jubilant Main Business
5.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.6.4 Jubilant Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 Jubilant Recent Developments
5.7 Famar
5.7.1 Famar Profile
5.7.2 Famar Main Business
5.7.3 Famar Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.7.4 Famar Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 Famar Recent Developments
5.8 Boehringer Ingelheim
5.8.1 Boehringer Ingelheim Profile
5.8.2 Boehringer Ingelheim Main Business
5.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.8.4 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Boehringer Ingelheim Recent Developments
5.9 Fareva Holding
5.9.1 Fareva Holding Profile
5.9.2 Fareva Holding Main Business
5.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.9.4 Fareva Holding Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Fareva Holding Recent Developments
5.10 AbbVie Contract Manufacturing
5.10.1 AbbVie Contract Manufacturing Profile
5.10.2 AbbVie Contract Manufacturing Main Business
5.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.10.4 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 AbbVie Contract Manufacturing Recent Developments
5.11 Nipro Pharma
5.11.1 Nipro Pharma Profile
5.11.2 Nipro Pharma Main Business
5.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.11.4 Nipro Pharma Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Nipro Pharma Recent Developments
5.12 Sopharma
5.12.1 Sopharma Profile
5.12.2 Sopharma Main Business
5.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.12.4 Sopharma Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Sopharma Recent Developments
5.13 Mylan (DPT Laboratories)
5.13.1 Mylan (DPT Laboratories) Profile
5.13.2 Mylan (DPT Laboratories) Main Business
5.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.13.4 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Mylan (DPT Laboratories) Recent Developments
5.14 Recipharm
5.14.1 Recipharm Profile
5.14.2 Recipharm Main Business
5.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.14.4 Recipharm Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Recipharm Recent Developments
5.15 NextPharma
5.15.1 NextPharma Profile
5.15.2 NextPharma Main Business
5.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.15.4 NextPharma Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 NextPharma Recent Developments
5.16 Dishman
5.16.1 Dishman Profile
5.16.2 Dishman Main Business
5.16.3 Dishman Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.16.4 Dishman Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.16.5 Dishman Recent Developments
5.17 Aesica Pharmaceuticals
5.17.1 Aesica Pharmaceuticals Profile
5.17.2 Aesica Pharmaceuticals Main Business
5.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.17.4 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.17.5 Aesica Pharmaceuticals Recent Developments
5.18 CordenPharma
5.18.1 CordenPharma Profile
5.18.2 CordenPharma Main Business
5.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Products, Services and Solutions
5.18.4 CordenPharma Oral Solid Dosage Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.18.5 CordenPharma Recent Developments
6 North America
6.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oral Solid Dosage Contract Manufacturing Market Dynamics
11.1 Oral Solid Dosage Contract Manufacturing Industry Trends
11.2 Oral Solid Dosage Contract Manufacturing Market Drivers
11.3 Oral Solid Dosage Contract Manufacturing Market Challenges
11.4 Oral Solid Dosage Contract Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
